Biodexa Pharmaceuticals PLC, an acquisition-focused clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs, today ...
SHANGHAI, Jan. 10, 2025 /PRNewswire/ -- Boqii Holding Limited ("Boqii" or the "Company") (NYSE American: BQ) today announced that it will change its ratio of its American Depositary Shares ("ADSs") to ...
Biodexa Pharmaceuticals PLC has announced a change in its American Depositary Receipts (ADR) ratio, effective July 31, 2025. The new ratio will be one ADR representing 100,000 ordinary shares, up from ...
BURLINGTON, Mass. and JERUSALEM, Feb. 17, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain stimulation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results